Results 61 to 70 of about 23,000 (252)
Human Vaccines & Immunotherapeutics, 2013 Japanese encephalitis (JE) is an infectious disease of the central nervous system caused by Japanese encephalitis virus (JEV), a zoonotic mosquito-borne flavivirus. JEV is prevalent in much of Asia and the Western Pacific, with over 4 billion people living at risk of infection.
Yun, Sang-Im, Lee, Young-Min
openaire +2 more sources
Acta Paediatrica, EarlyView.ABSTRACT The incidence of Tick‐borne encephalitis (TBE) cases has increased. The presumed location of transmission of Tick‐borne encephalitis virus (TBEV) has been expanding increasingly in the western parts of Europe during the past decade. There has also been an increased incidence of surveillance‐reported TBE cases in southern Sweden and southern ...
H. H. Askling, D. Zavadska
wiley +1 more source
DharmaJapanese Encephalitis (JE) is an infectious disease of the central nervous system caused by the Japanese Encephalitis Virus (JEV), JEV is the main cause of viral encephalitis in Asia. This virus is transmitted by mosquitoes and is zoonotic.
Siti Naimah, Jennifa Jennifa
doaj +1 more source
Canadian Journal of Infectious Diseases and Medical Microbiology, 2019 The attenuated Japanese encephalitis virus (JEV) live vaccine SA14-14-2 prepared from wild-type (WT) strain SA14 was licensed to prevent Japanese encephalitis (JE) in 1989 in China.
Rong Huang +5 more
doaj +1 more source
Physico-chemical requirements and kinetics of membrane fusion of flavivirus-like particles. [PDF]
, 2015 Flaviviruses deliver their RNA genome into the host-cell cytoplasm by fusing their lipid envelope with a cellular membrane. Expression of the flavivirus pre-membrane and envelope glycoprotein genes in the absence of other viral genes results in the ...
core +1 more source
Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet [PDF]
, 2014 Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to
Bhushan R. Deshpande +9 more
core +1 more source
Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design
Immunological Reviews, Volume 338, Issue 1, March 2026.ABSTRACT Vaccination represents one of the most impactful public health achievements, preventing 3.5 to 5 million deaths annually according to estimates of the World Health Organization. Yet, recent outbreaks of emerging and reemerging infectious diseases highlight the need for rapid and strategic vaccine development using vaccine platforms ...
Ilka Grewe +2 more
wiley +1 more source
Epidemiology of Japanese encephalitis in the Philippines: a systematic review.
PLoS Neglected Tropical Diseases, 2015 BackgroundJapanese encephalitis virus (JEV) is an important cause of encephalitis in most of Asia, with high case fatality rates and often significant neurologic sequelae among survivors. The epidemiology of JE in the Philippines is not well defined.
Anna Lena Lopez +9 more
doaj +1 more source
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries. [PDF]
, 2018 With social policies increasingly directed toward enhancing equity through health programs, it is important that methods for estimating the health and economic benefits of these programs by subpopulation be developed, to assess both equity concerns and ...
Brenzel, Logan +16 more
core +2 more sources
Nano Select, Volume 7, Issue 2, February 2026.This review explores nanoparticle (NP)‐based biosensors and nanovaccine platforms for arboviral infections, highlighting their design, performance, and translational potential. By comparing case studies across viruses, it identifies gold‐standard nanomaterials such as gold NPs (AuNPs), zinc oxide NPs (ZnONPs), molybdenum disulfide (MoS2) nanocomposites,
Peyman Halvaeikhanekahdani +3 more
wiley +1 more source